Company profile: Cenexi
1.1 - Company Overview
Company description
- Provider of sterile pharmaceutical manufacturing and CDMO services, covering drug development, production, and regulatory support. Delivers formulation, analytical development, industrial transfer, and regulatory affairs. Produces prefilled syringes, liquid and lyophilized vials, and ampoules, including high potent and biological products; up to 37m syringes, 68m vials, and 410m ampoules annually.
Products and services
- Contract Development and Manufacturing Organization (CDMO): Cenexi delivers comprehensive outsourcing for pharmaceutical companies covering drug development, manufacturing, and regulatory support with an industrial-grade framework for sterile pharmaceutical products
- Ampoules: Cenexi produces up to 410 million sterile ampoules annually for conventional, high potent, and biological products, delivering high-volume capacity
- Liquid and Lyophilized Vials: Cenexi fabricates up to 68 million sterile liquid and lyophilized vials per year for conventional, high potent, and biological products, featuring lyophilization-capable production
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cenexi
Creative Peptides
HQ: United States
Website
- Description: Provider of custom peptide synthesis and process development, specializing in bioactive peptides from small-scale research to large-scale clinical and commercial production. Offers peptide modifications (phosphorylation, glycosylation, lipidation), analysis, pharmaceutical peptide development support (formulation, regulatory compliance), GMP manufacturing for trials and commercial use, and catalog products, including protein glycosylation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Creative Peptides company profile →
ClinEdge
HQ: United States
Website
- Description: Provider of a full suite of clinical and trial management solutions to clinical research institutions, pharmaceutical companies, and CROs, providing business development and patient recruitment services and facilitating every stage of the clinical trial process, from site selection to staff support to patient engagement.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ClinEdge company profile →
Percuro
HQ: Brazil
Website
- Description: Provider of clinical research and health services, committed to the provision of effective treatments in a safe and supportive environment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Percuro company profile →
Clinical Trials Laboratory
HQ: United Kingdom
Website
- Description: Provider of outsourcing laboratory services procuring high-quality serum, plasma, blood, and blood cells for clinical research across pharmaceutical, bioanalytical, biotechnology, clinical trials, diagnostic, and drug industries. Offers blood donation services collecting biofluids, leukapheresis for white blood cell collection, and donor recruitment and management to ensure a steady supply of biological specimens.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinical Trials Laboratory company profile →
Reaction Biology
HQ: United States
Website
- Description: Provider of assay services and protein production for early-stage drug discovery, including biochemical, biophysical, electrophysiological and cell assays for high throughput screening (HTS); kinase and epigenetic assays; recombinant and custom protein production; 2D/3D cell-based assays; in vivo pharmacology (xenograft, immuno-oncology tumor models); and ADME & safety with in vitro safety screening, cardiac safety assessment, and in vivo PK/PD studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Reaction Biology company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cenexi
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cenexi
2.2 - Growth funds investing in similar companies to Cenexi
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cenexi
4.2 - Public trading comparable groups for Cenexi
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →